Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan
Authors
Keywords
Rashes, Aminotransferases, Hepatitis C virus, HIV, Antiretroviral therapy, Co-infections, Regression analysis, Adverse events
Journal
PLoS One
Volume 12, Issue 2, Pages e0171596
Publisher
Public Library of Science (PLoS)
Online
2017-02-22
DOI
10.1371/journal.pone.0171596
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
- (2016) Helen Kovari et al. Open Forum Infectious Diseases
- Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan
- (2015) Chung-Chih Lai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Presence of Tablet Remnants of Nevirapine Extended-Release in Stools and Its Impact on Virological Outcome in HIV-1-Infected Patients: A Prospective Cohort Study
- (2015) Yi-Chieh Lee et al. PLoS One
- Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan
- (2014) Yu-Tzu Tseng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Therapeutic Drug Monitoring and Pharmacogenetic Study of HIV-Infected Ethnic Chinese Receiving Efavirenz-Containing Antiretroviral Therapy with or without Rifampicin-Based Anti-Tuberculous Therapy
- (2014) Kuan-Yeh Lee et al. PLoS One
- Seroprevalence of Hepatitis B Virus among Adults at High Risk for HIV Transmission Two Decades after Implementation of Nationwide Hepatitis B Virus Vaccination Program in Taiwan
- (2014) Hsin-Yun Sun et al. PLoS One
- Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine's Epitaph?
- (2014) Fred Stephen Sarfo et al. PLoS One
- Multicenter Study of Trimethoprim/Sulfamethoxazole-Related Hepatotoxicity: Incidence and Associated Factors among HIV-Infected Patients Treated for Pneumocystis jirovecii Pneumonia
- (2014) Jen-Jia Yang et al. PLoS One
- Adverse events associated with nevirapine use in pregnancy
- (2013) Nathan Ford et al. AIDS
- Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy
- (2013) Zara Shubber et al. AIDS
- Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study
- (2013) Anne F. Luetkemeyer et al. CLINICAL INFECTIOUS DISEASES
- Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials
- (2013) J-M Molina et al. HIV MEDICINE
- Slow immunological progression in HIV-1 CRF07_BC-infected injecting drug users
- (2013) Pi-Han Lin et al. Emerging Microbes & Infections
- Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials
- (2012) Calvin J. Cohen et al. AIDS
- Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials
- (2012) M. Nelson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan
- (2012) Chung-Chih Lai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cost-effectiveness of antiretroviral regimens in the World Health Organizationʼs treatment guidelines: a South African analysis
- (2010) Eran Bendavid et al. AIDS
- Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya
- (2010) PJ Peters et al. HIV MEDICINE
- Nevirapine-Associated Early Hepatotoxicity: Incidence, Risk Factors, and Associated Mortality in a Primary Care ART Programme in South Africa
- (2010) Kathryn M. Chu et al. PLoS One
- Seroprevalence of Chronic Hepatitis B Virus Infection Among Taiwanese Human Immunodeficiency Virus Type 1–Positive Persons in the Era of Nationwide Hepatitis B Vaccination
- (2009) Hsin-Yun Sun et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Hepatotoxicity Associated with Long- versus Short-Course HIV-Prophylactic Nevirapine Use
- (2009) June M. McKoy et al. DRUG SAFETY
- HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients
- (2009) Soranun Chantarangsu et al. Pharmacogenetics and Genomics
- HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients
- (2009) Sirirat Likanonsakul et al. AIDS Research and Therapy
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started